What's New at Charles River
   
 
 
   
   

Methylazoxymethanol (MAM) Acetate-Induced Model for Schizophrenia Research Now Available

August 13, 2012  - Exposure of pregnant rats (multiple strains) on gestational day (GD) 17 to methylazoxymethanol (MAM) acetate results in disrupted neurogenesis in offspring that later in life show subtle behavioral changes, cognitive deficits, neurochemical changes and neuropathology that mimic those seen in schizophrenia patients. The MAM rat model is a valuable research tool, useful in identifying drug candidates that would not be discovered through traditional screens for antipsychotics. In addition, the model shows value as a developmental model to be used to identify genes that may be contributory in abnormal cortical neurogenesis and function.

To learn more about this surgical model, click here. For more information on our MAM acetate-induced model, as well as other neurological procedures, please contact us at askcharlesriver@crl.com.

Related Information

   
Discover the full range of Charles River Products and Services
The Source

For more information, contact us at:

1.877.CRIVER.1 (1.877.274.8371)
askcharlesriver@crl.com

view all

News & Events

view all
Apr 11 - Access New and Updated Clinical Pa...
Mar 20 - TARGATT™ Mouse for Reliable Target...
Jun 10-Jun 13 - Barcelona, Spain - FELASA - SECAL 2013
May 21-May 24 - Berlin, Germany - RDD Europe 2013
May 23-May 23 - East Lansing, Michigan, USA - The Ins and Outs of Transgenic Colongy Ma...

Charles River Laboratories, Inc.